Mean platelet volume in recurrent aphthous stomatitis and Behçet disease

Angiology

Volumn 65, Issue 2, 2014, Pages 161-165

  Ekiz, Ozlem ^a   Balta, Ilknur ^b   Sen, Bilge Bulbul ^a   Rifaioglu, Emine Nur ^a   Ergin, Can ^c   Balta, Sevket ^d   Demirkol, Sait ^d  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b Research Hospital   (Turkey)

^c DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Behcet disease; mean platelet volume; recurrent aphthous stomatitis; vascular

Indexed keywords

BIOLOGICAL MARKER;

ADULT; APHTHOUS STOMATITIS; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; THROMBOCYTE VOLUME;

EID: 84891843811     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713492375     Document Type: Article

References (40)

1. Balta I, Balta S, Demirkol S, Ekiz O Rheumatol Int. 2013:
2. Ural AU, Yalcin A, Beyan C, Isimer A, Bayhan H. Plasma endothelin-1 concentrations in patients with Behçet's disease. Scand J Rheumatol. 1994 ; 23 (6). 322-325
3. Jagroop IA, Mikhailidis DP. Effect of endothelin-1 on human platelet shape change: reversal of activation by naftidrofuryl. Platelets. 2000 ; 11 (5). 272-277
4. Davatchi F, Shahram F, Chams-Davatchi C, et al. Behcet's disease: from east to west. Clin Rheumatol. 2010 ; 29 (8). 823-833
5. Kiraz S, Ertenli I, Oztürk MA, Haznedaroǧlu IC, Celik I, Calgüneri M. Pathological haemostasis and "prothrombotic state" in Behçet's disease. Thromb Res. 2002 ; 105 (2). 125-133
6. Chavan M, Jain H, Diwan N, Khedkar S, Shete A, Durkar S. Recurrent aphthous stomatitis: a review. J Oral Pathol Med. 2012 ; 41 (8). 577-583
7. Kiraz S, Ertenli I, Oztürk MA, Haznedaroǧlu IC, Celik I, Calgüneri M. Pathological haemostasis and "prothrombotic state" in Behçet's disease. Thromb Res. 2002 ; 105 (2). 125-133
8. Ghate J V, Jorizzo JL.. Behçet's disease and complex aphthosis. J Am Acad Dermatol. 1999 ; 40 1: 1-18
9. Sandhaus LM, Meyer P. How useful are CBC and reticulocyte reports to clinicians?. Am J Clin Pathol. 2002 ; 118 (5). 787-793
10. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996 ; 7 (2). 157-161
11. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol. 2001 ; 96 (3). 776-781
12. Kisacik B, Tufan A, Kalyoncu U, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine. 2008 ; 75 (3). 291-294
13. Yazici S, Yazici M, Erer B, Calik Y, Ozhan H, Ataoglu S. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets. 2010 ; 21 (2). 122-125
14. Balta S, Demirkol S, Cakar M, Celik T Platelets. 2013:
15. Acikgoz N, Karincaoglu Y, Ermis N, et al. Increased mean platelet volume in Behçet's disease with thrombotic tendency. Tohoku J Exp Med. 2010 ; 221 (2). 119-123
16. International Study Group for Behçet's Disease. Lancet. 1990 ; 335 (8697). 1078-1080
17. Balta S, Demirkol S, Celik T, et al Angiology. 2013: 627-632.
18. Pekiner FN, Aytugar E, Demirel GY, Borahan MO. Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations. J Oral Pathol Med. 2012 ; 41 (1). 73-79
19. Macey M, Hagi-Pavli E, Stewart J, et al. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease. Rheumatology (Oxford, England). 2011 ; 50 (10). 1849-1859
20. Pamuk GE, Pamuk ON, Orüm H, Demir M, Turgut B, Cakir N. Might platelet-leucocyte complexes be playing a role in major vascular involvement of Behçet's disease? A comparative study. Blood Coagul Fibrinolysis. 2010 ; 21 (2). 113-117
21. Akar S, Ozcan MA, Ateş H, et al. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease. Clin Appl Thromb Hemost. 2006 ; 12 (4). 451-457
22. Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K.. Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol. 2002 ; 31 (4). 205-210
23. Kaser A, Brandacher G, Steurer W, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001 ; 98 (9). 2720-2725
24. Demirkol S, Balta S, Unlu M, et al. Evaluation of the mean platelet volume in patients with cardiac syndrome X. Clinics (São Paulo, Brazil). 2012 ; 67 (9). 1019-1022
25. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation?. Curr Pharm Des. 2011 ; 17 (1). 47-58
26. Atzeni F, Boiardi L, Nicoli D, et al. PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease. Clin Exp Rheumatol. 29 (4 suppl 67). 38-43
27. Tunc SE, Aksu K, Keser G, et al. Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet's patients. Rheumatol Int. 2005 ; 25 (5). 326-331
28. Martínez M, Ricart JM, Ruiz-Aja S, et al. Platelet activation and red blood cell phosphatidylserine exposure evaluated by flow cytometry in patients with Behçet's disease: are they related to thrombotic events?. Pathophysiol Haemost Thromb. 2007 ; 36 (1). 18-22
29. Fernández Bello I, Álvarez MT, López-Longo FJ, et al. Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients. Thromb Haemost. 2012 ; 107 (1). 88-98
30. Yoshida H, Granger DN. Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflamm Bowel Dis. 2009 ; 15 (8). 1245-1255
31. Yüksel O, Helvaci K, Başar O, et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets. 2009 ; 20 (4). 277-281
32. Kisacik B, Tufan A, Kalyoncu U, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine. 2008 ; 75 (3). 291-294
33. Yazici S, Yazici M, Erer B, et al. The platelet functions in patients with ankylosing spondylitis: anti-TNF-alpha therapy decreases the mean platelet volume and platelet mass. Platelets. 2010 ; 21 (2). 126-131
34. Yazici S, Yazici M, Erer B, Calik Y, Ozhan H, Ataoglu S. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets. 2010 ; 21 (2). 122-125
35. Gasparyan AY, Stavropoulos-Kalinoglou A, Toms TE, Douglas KMJ, Kitas GD. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets. 2010 ; 9 (1). 45-50
36. Karabudak O, Ulusoy RE, Erikci AA, Solmazgul E, Dogan B, Harmanyeri Y. Inflammation and hypercoagulable state in adult psoriatic men. Acta Derm Venereol. 2008 ; 88 (4). 337-340
37. Canpolat F, Akpinar H, Eskioǧlu F. Mean platelet volume in psoriasis and psoriatic arthritis. Clin Rheumatol. 2010 ; 29 (3). 325-328
38. Ekiz F, Yüksel O, Koçak E, et al. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal. 2011 ; 25 (3). 162-165
39. Ekiz F, Gürbüz Y, Basar O, et al. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever [published online March 19, 2012]. Clin Appl Thromb Hemost. 2012 ;:
40. Balta S, Demirkol S, Kucuk U, et al. Mean platelet volume may be related to the degree of coronary collateral circulation. Eur Rev Med Pharmacol Sci. 2013 ; 17 (5). 707-708